Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-02
DOI
10.3389/fimmu.2021.813957
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
- (2021) Giacomo Boffa et al. NEUROLOGY
- Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
- (2021) J Das et al. Multiple Sclerosis Journal
- The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge
- (2021) Iván Murrieta-Álvarez et al. Frontiers in Neurology
- New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis
- (2021) Richard K. Burt et al. BONE MARROW TRANSPLANTATION
- Early Aggressive Treatment Approaches for Multiple Sclerosis
- (2021) Alexandra Simpson et al. Current Treatment Options in Neurology
- Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy
- (2021) Binod Dhakal et al. BLOOD
- Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
- (2021) Raffaella Greco et al. BONE MARROW TRANSPLANTATION
- B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
- (2021) Maria T. Cencioni et al. Nature Reviews Neurology
- Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis
- (2021) Richard S. Nicholas et al. NEUROLOGY
- Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant
- (2021) Hayley Colton et al. VACCINE
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
- (2021) Kazimieras Maneikis et al. Lancet Haematology
- Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
- (2021) Patrick Harrington et al. CANCER CELL
- Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
- (2021) Richard K. Burt et al. JOURNAL OF NEUROLOGY
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
- (2021) Steve Simpson-Yap et al. NEUROLOGY
- Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status
- (2020) Alice Mariottini et al. BIODRUGS
- Aggressive multiple sclerosis: a single center, real‐world treatment experience
- (2020) G. Boffa et al. EUROPEAN JOURNAL OF NEUROLOGY
- Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes
- (2020) Hossam A. Abdelsamed et al. NATURE IMMUNOLOGY
- Effects of MS disease-modifying therapies on responses to vaccinations: A review.
- (2020) John Robert Ciotti et al. Multiple Sclerosis and Related Disorders
- Cladribine vs other drugs in MS
- (2020) Alessio Signori et al. Neurology-Neuroimmunology & Neuroinflammation
- Hematopoietic Stem Cell Transplantation for Autoimmune Disease
- (2020) Tobias Alexander et al. Annual Review of Medicine
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Catherine Cordonnier et al. LANCET INFECTIOUS DISEASES
- Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation
- (2019) Jeffrey A. Cohen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The pathogenicity of Th17 cells in autoimmune diseases
- (2019) Keiko Yasuda et al. Seminars in Immunopathology
- Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis
- (2019) Diane Larsson et al. Multiple Sclerosis Journal
- Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation
- (2019) Andreas Tolf et al. ACTA NEUROLOGICA SCANDINAVICA
- Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
- (2019) Basil Sharrack et al. BONE MARROW TRANSPLANTATION
- Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
- (2019) Lana Zhovtis Ryerson et al. NEUROLOGY
- CD4 + memory stem T cells recognizing citrullinated epitopes are expanded in patients with Rheumatoid Arthritis and sensitive to TNF‐α blockade
- (2019) Beatrice C Cianciotti et al. Arthritis & Rheumatology
- Human blood MAIT cell subsets defined using MR1 tetramers
- (2018) Nicholas A Gherardin et al. IMMUNOLOGY AND CELL BIOLOGY
- Role of stem cell-like memory T cells in systemic lupus erythematosus
- (2018) Ye Ji Lee et al. Arthritis & Rheumatology
- Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
- (2018) Peter J. Darlington et al. Frontiers in Immunology
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis
- (2018) A. Mariottini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
- (2018) John J Moore et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant
- (2018) Paul D.E Miller et al. VACCINE
- Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis
- (2018) Maria R Ciardi et al. Open Forum Infectious Diseases
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
- (2017) Paolo A. Muraro et al. Nature Reviews Neurology
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation for MS
- (2017) Joachim Burman et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
- (2017) Richard A. Nash et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
- (2017) David Baker et al. JAMA Neurology
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
- (2016) Zachariah DeFilipp et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation
- (2016) Lucas C.M. Arruda et al. CLINICAL IMMUNOLOGY
- T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis
- (2016) Patrick Blanco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis
- (2016) Luca Prosperini et al. JOURNAL OF NEUROLOGY
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
- (2016) Harold L Atkins et al. LANCET
- Human Stem Cell-like Memory T Cells Are Maintained in a State of Dynamic Flux
- (2016) Raya Ahmed et al. Cell Reports
- Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
- (2015) Nicoletta Cieri et al. BLOOD
- Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
- (2015) Daniela Curro’ et al. Multiple Sclerosis Journal
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory
- (2015) Giacomo Oliveira et al. Science Translational Medicine
- Long-lasting stem cell–like memory CD8 + T cells with a naïve-like profile upon yellow fever vaccination
- (2015) Silvia A. Fuertes Marraco et al. Science Translational Medicine
- In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells
- (2015) Luca Biasco et al. Science Translational Medicine
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
- (2015) Daniela Curro’ et al. Multiple Sclerosis Journal
- T cell repertoire following autologous stem cell transplantation for multiple sclerosis
- (2014) Paolo A. Muraro et al. JOURNAL OF CLINICAL INVESTIGATION
- Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
- (2014) Joachim Burman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
- (2014) H. Butzkueven et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
- (2014) A Kurioka et al. Mucosal Immunology
- Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
- (2013) Sofia V. Abrahamsson et al. BRAIN
- Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation
- (2012) Peter J. Darlington et al. ANNALS OF NEUROLOGY
- Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
- (2012) N S Majhail et al. BONE MARROW TRANSPLANTATION
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- MR1 presents microbial vitamin B metabolites to MAIT cells
- (2012) Lars Kjer-Nielsen et al. NATURE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human MAIT and CD8 cells develop from a pool of type-17 precommitted CD8+ T cells
- (2011) L. J. Walker et al. BLOOD
- Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
- (2011) J D Bowen et al. BONE MARROW TRANSPLANTATION
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
- (2011) GL Mancardi et al. Multiple Sclerosis Journal
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Long-term results of stem cell transplantation for MS: A single-center experience
- (2011) A. Fassas et al. NEUROLOGY
- Natalizumab dosage suspension: Are we helping or hurting?
- (2010) Timothy W. West et al. ANNALS OF NEUROLOGY
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
- (2010) M. Dusseaux et al. BLOOD
- Wnt/ -Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy
- (2010) L. Gattinoni et al. CLINICAL CANCER RESEARCH
- Antimicrobial activity of mucosal-associated invariant T cells
- (2010) Lionel Le Bourhis et al. NATURE IMMUNOLOGY
- Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells
- (2010) Marielle C. Gold et al. PLOS BIOLOGY
- Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients
- (2009) Sung-Nan Pei et al. ANNALS OF HEMATOLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- The Quest for CD8+ Memory Stem Cells
- (2009) Michael Neuenhahn et al. IMMUNITY
- A Distinct Subset of Self-Renewing Human Memory CD8+ T Cells Survives Cytotoxic Chemotherapy
- (2009) Cameron J. Turtle et al. IMMUNITY
- The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
- (2009) R. S. Akondy et al. JOURNAL OF IMMUNOLOGY
- Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
- (2009) Richard K Burt et al. LANCET NEUROLOGY
- Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
- (2009) Luca Gattinoni et al. NATURE MEDICINE
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation
- (2008) J Fagius et al. Multiple Sclerosis Journal
- Multiple Lessons for Multiple Sclerosis
- (2008) Stephen L. Hauser NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started